• Corpus ID: 29348202

A Strategy to Combine Sam ple Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization Graphical

@inproceedings{Erickson2016AST,
  title={A Strategy to Combine Sam ple Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization Graphical},
  author={Brian K. Erickson and Christopher M. Rose and Craig R. Braun and Alison R Erickson and Jeffrey Knott and Graeme C. McAlister and Jo{\~a}o A. Paulo and Robert A. Everley and Steven P. Gygi},
  year={2016}
}

Figures from this paper

References

SHOWING 1-10 OF 44 REFERENCES

Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays

Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines

The results of screening current Food and Drug Administration (FDA)-approved anticancer agents in the NCI60 screen are described, with an emphasis on those agents that target signal transduction.

MARQUIS: A Multiplex Method for Absolute Quantification of Peptides and Post-Translational Modifications

A novel mass spectrometry-based approach using a combination of isobaric tags and heavy-labeled standard peptides to construct internal standard curves for peptides derived from key nodes in signal transduction networks, enabling a quantitative comparison of EGFRosphorylation sites and demonstrating that receptor phosphorylation is qualitatively similar but quantitatively distinct for each EGFR ligand tested.

ms3 eliminates ratio distortion in isobaric multiplexed quantitative

This model was used to evaluate several analytical strategies as potential solutions to the outlined diffi-culties, and it is shown that performing an additional isolation and fragmentation event (MS3 scan) overcomes these problems by eliminating the interference effect.

Gas-phase purification enables accurate, large-scale, multiplexed proteome quantification with isobaric tagging

This technique enables large-scale, multiplexed quantitative proteomics using isobaric tagging, and shows substantially improved quantitative accuracy compared to a standard scan, with a small loss of spectral identifications.

Delayed fragmentation and optimized isolation width settings for improvement of protein identification and accuracy of isobaric mass tag quantification on Orbitrap-type mass spectrometers.

By delaying peptide fragmentation to occur closer to the apex of the chromatographic peak in liquid chromatography-tandem mass spectrometry (LC-MS/MS) experiments cofragmentation is reduced by 2-fold and peptides are fragmented with 2.8-fold better signal-to-noise ratios, which results in significantly improved accuracy of isobaric mass tag based quantification.

Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.

By demonstrating the elevated HER2 expression in a hormone-dependent breast cancer cell line overexpressing ERbeta1, the data suggest the presence of cross-talk between the two receptors, one of the molecular mechanisms underlying the significant ERbeta/HER2 co-expression observed in recent clinical studies.

Recent advances in targeted proteomics for clinical applications

The recent introduction of targeted high‐resolution and accurate‐mass analyses on fast sequencing mass spectrometers operated in parallel reaction monitoring (PRM) mode offers new avenues to conduct clinical studies and thus overcome some of the limitations of the triple quadrupole instrument.

A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion

An approach involving blood stem cells to discover host factors critical for Plasmodium falciparum infection of red blood cells and identified an essential host receptor for parasite invasion that could provide a target for malaria therapeutics.

Increasing throughput in targeted proteomics assays: 54-plex quantitation in a single mass spectrometry run.

The 54-plex approach resulted in a significant reduction in purification resources (time, reagents, etc.) and a ~50-fold improvement in acquisition throughput and was demonstrated in several ways including measuring inhibition of PKA activity in MCF7 cell lysates for a panel of nine compounds.